Cart
sales@molnova.com
PKUMDL-WQ-2101
CAS No. 304481-72-9
PKUMDL-WQ-2101( —— )
Catalog No. M27914 CAS No. 304481-72-9
PKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 36 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 50MG | 133 | In Stock |
|
| 100MG | 231 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePKUMDL-WQ-2101
-
NoteResearch use only, not for human use.
-
Brief DescriptionPKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.
-
DescriptionPKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.
-
In VitroCell Viability Assay Cell Line:MDA-MB-468 cells Concentration:2.5 μM, 5.0 μM, 20 μM and 40 μM Incubation Time:24 hours Result:Caused cell cycle arrest.
-
In VivoAnimal Model:NOD.CB17 Scid/J mice injected with MDA-MB-468 cellsDosage:5 mg/kg, 10 mg/kg, 20 mg/kg Administration:i.p; daily; for 30 days Result:Exhibited substantial inhibitory effects on MDA-MB-468 xenografts.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPDE9A|PDE5A1|PDE1B|PDE4D2|PDE10A1|PDE2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number304481-72-9
-
Formula Weight317.26
-
Molecular FormulaC14H11N3O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (394.01 mM)
-
SMILESO=C(N/N=C/C1=CC([N+]([O-])=O)=CC=C1O)C2=CC=C(O)C=C2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
pTH (1-37) (human)
pTH (1-37) (human) is a fragment of parathyroid hormone (PTH). pTH (1-37) (human) induces the cAMP formation and increases alkaline phosphatase activity. pTH (1-37) (human) increases growth, bone calcium content, and bone mineral density (BMD) in uremic animals. pTH (1-37) (human) has the potential for the research of osteoporosis.
-
Crilvastatin
Crilvastatin (PMD 387) is a novel, non-competitive hydroxymethylglutaryl coenzyme A reductase inhibitor with cholesterol-lowering activity, inhibiting cholesterol uptake in rats with hereditary hypercholesterolemia.
-
SHMT-IN-2
SHMT-IN-2 (compound 2) is a specific human SHMT1/2 small molecule inhibitor that acts on SHMT1 (IC50: 13 nM) and SHMT2 (IC50: 66 nM). SHMT-IN-2 inhibits the growth of many human cancer cells and is sensitive to B-cell lymphoma.
